Developmental defects in a Caenorhabditis elegans model for type III galactosemia

Area of Science:

• Biochemistry
• Genetics
• Developmental Biology

Background:

• Type III galactosemia is a metabolic disorder linked to UDP-galactose-4-epimerase deficiency.
• This enzyme is crucial for galactose metabolism and producing essential UDP-sugar molecules.

Purpose of the Study:

• To investigate the function of the UDP-galactose-4-epimerase gene (gale-1) in Caenorhabditis elegans.
• To understand the consequences of gale-1 mutations on development, galactose sensitivity, and infection response.

Main Methods:

• Characterization of gale-1 loss-of-function and partial loss-of-function mutations in C. elegans.
• Assessment of developmental abnormalities, galactose hypersensitivity, and infection susceptibility in gale-1 mutants.
• Exploration of interactions between gale-1 and the unfolded protein response pathway.

Main Results:

• Complete gale-1 loss-of-function mutation resulted in lethality, supporting hypotheses for human Type III galactosemia.
• Partial gale-1 loss-of-function alleles led to developmental abnormalities, likely due to impaired glycosylation.
• gale-1 mutants exhibited hypersensitivity to both galactose exposure and infections.
• Significant interactions were identified between gale-1 and the unfolded protein response.

Conclusions:

• The C. elegans gale-1 gene is essential for normal development and survival, mirroring human Type III galactosemia.
• Impaired glycosylation resulting from reduced UDP-galactose-4-epimerase activity underlies developmental defects and increased susceptibility to stress.
• The unfolded protein response is implicated in the cellular response to gale-1 dysfunction.